Skip to main content
SpringerLink
Log in
Book cover

Therapiekonzepte Onkologie pp 46–49Cite as

Myelodysplastische Syndrome

  • Chapter

  • 31 Accesses

Zusammenfassung

Heterogene Gruppe von Erkrankungen mit den gemeinsamen Charakteristika einer monoklonalen Hämatopoese mit normo- oder hyperzellulärem Knochenmark und peripherer Zytopenie einer oder mehrerer hämatopoetischer Zeltreihen aufgrund einer Störung von Zellproliferation und Differenzierung pluripotenter Stammzellen.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aul C, Gattermann N, Schneider W (1992) Age — related incidence and other epidemiological aspects of myelodysplastic syndromes. Brit J Haemat 82: 358–367

    Article  PubMed  CAS  Google Scholar 

  2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) French-American-British (FAB) cooperative group. Proposals for the classifiction of myelodysplastic syndromes. Br J Haemat: 189–199

    Google Scholar 

  3. Goasguen JE, Bennett JM (1992) Classification and morphologic features of the myelodysplastic syndromes. Sem Oncol 19: 4–13

    CAS  Google Scholar 

  4. Mufti GJ (1992) A guide to risk assessment in the primary myelodysplastic syndrome. Hematology/Oncology Clinics of North America 6: 587–606

    PubMed  CAS  Google Scholar 

  5. Wörmann B (in Druck) Myelodysplastisches Syndrom und sekundäre Leukämie. Internist

    Google Scholar 

  6. Vadhan Raj S, Keating M, LeMaistre A, Hittelman WN, McCredie K, Trujillo JM, Broxmeyer HE, Henney C, Gutterman JU (1987) Effects of recombinant human granulocyte — macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 317: 1545–1552

    Article  PubMed  CAS  Google Scholar 

  7. Büchner T, Hiddemann W, Blasius S et al (1990) The role of chemotherapy intensity and duration. Two studies of the AMLCG. In: Büchner T, Schellong G, Hiddemann W, Ritter J (eds) Acute Leukemias II. Springer Verlag, Heidelberg Berlin:261–266

    Google Scholar 

  8. Mertelsmann R, Thaler H, To L et al (1980) Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia. Blood 56: 773–781

    PubMed  CAS  Google Scholar 

  9. Armitage JO, Dick FR, Needleman SW, Burns CP (1981) Effect of chemotherapy for the dysmyelopoietic syndrome. Cancer Treat Rep 65: 601–605

    PubMed  CAS  Google Scholar 

  10. Tricot G, Boogaerts MA (1986) The role of aggressive chemotherapy in the treatment of the myelodysplastic syndromes. Br J Haemat 63: 477–483

    Article  CAS  Google Scholar 

  11. Fenaux P, Lai L, Jouet JP, Poltet JP, Bauters F (1988) Aggressive chemotherapy in adult primary myelodysplastic syndromes. Blut 57: 297–302

    Article  PubMed  CAS  Google Scholar 

  12. Aul C, Schneider W (1989) The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromes. Cancer 64: 1812–1818

    Article  PubMed  CAS  Google Scholar 

  13. Cheson BD (1992) Chemotherapy and bone marrow transplantation for myelodysplasic syndromes. Sem Oncol 19: 85–94

    CAS  Google Scholar 

  14. Appelbaum FR, Barrall J, Storb R et al. (1990) Bone marrow transplantation for patients with myelodysplasia. Ann Int Med 112: 590–597

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. W. Hiddemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen, Deutschland

    Siegfried Seeber  & Jochen Schütte  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hiddemann, W. (1993). Myelodysplastische Syndrome. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10495-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10495-8_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56872-8

  • Online ISBN: 978-3-662-10495-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation